Home › Photophobia › Michigan
Photophobia clinical trials in Michigan
3 studies for Photophobia are looking for participants at sites in Michigan.
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Michigan Head Pain and Neurological Institute, Ann Arbor
- Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
- Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
- and 1 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Michigan Head Pain & Neurological Institute, Ann Arbor
- Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
- Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04649242Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NRST - Detroit, Detroit
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 14, 2026 · NCT05156398From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.